Remo CRO

News

New cancer drug safely boosts radiation therapy

11.15 2018.

A new clinical trial finds that a novel drug can boost the strength of radiation therapy in the fight against cancer with ‘minimal side effects.’ Details

Vitamin D, fish oil supplements of little benefit to heart health

11.13 2018.

Two large new clinical trials have examined the benefits of vitamin D and fish oil supplements for staving off heart disease and cancer. Details

Entasis Therapeutics Announces Zoliflodacin Phase 2 Results Published in The New England Journal of Medicine

11.09 2018.

WALTHAM, Mass., Nov. 07, 2018 (GLOBE NEWSWIRE) — Entasis Therapeutics (NASDAQ: ETTX), a clinical-stage biopharmaceutical company focused on the discovery and development of novel antibacterial products, announced that The New England journal of… Details

Janssen Reports Positive Topline Results for FLAIR Phase 3 Study of a Novel, Long Acting Injectable Two-Drug Regimen for the treatment of HIV-1

11.08 2018.

CORK, IRELAND, October 31, 2018 – The Janssen Pharmaceutical Companies of Johnson & Johnson today confirmed positive topline results from the global, Phase 3 FLAIR (First Long-Acting Injectable Regimen) study of a long-acting, injectable… Details

Major depression: Existing drug reduces symptoms by 45 percent

11.04 2018.

An existing drug that people use to treat seizures can significantly reduce symptoms of major depressive disorder in a small number of participants. Details

New STAIRWAY Study Data Shows Potential for Extended Durability With Faricimab in Wet Age-Related Macular Degeneration (AMD)

11.01 2018.

South San Francisco, CA — October 27, 2018 — Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced positive results from the Phase II STAIRWAY study which explored the extended durability of faricimab (RG7716) in the… Details